US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
カナダ
CSE
Tokenwell Platforms Inc (TWEL) 銘柄情報

Tokenwell Platforms Inc (TWEL)

0.025

0.005

( 25.00% )

更新日時： 22:30:00

Tokenwell Platforms Inc (TWEL) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.025

( 25.00% )

買値

0.02

売値

0.025

出来高

52,000

0.025 日の範囲 0.025

0.02 52 週間の範囲 0.48

時価総額

前日終値

0.02

始値

0.025

時刻

最終取引時間

23:03:07

財務取引量

-

VWAP

-

平均取引量 (3 か月)

$ 106,139

発行済株式数

61,533,092

配当利回り

PER

-0.2

1 株当たり利益 (EPS)

-0.1

歳入

-

純利益

-4.9M

Tokenwell Platforms Inc., a financial technology company that focuses on enhancing access to intelligent digital asset investing through software platforms in Canada. The company was formerly known as Trilogy AI Corp. and changed its name to Tokenwell Platforms Inc. in August 2025. Tokenwell Platfor... Tokenwell Platforms Inc., a financial technology company that focuses on enhancing access to intelligent digital asset investing through software platforms in Canada. The company was formerly known as Trilogy AI Corp. and changed its name to Tokenwell Platforms Inc. in August 2025. Tokenwell Platforms Inc. was incorporated in 2019 and is headquartered in Vancouver, Canada. 詳細を表示

セクター

Finance

業界

Capital Markets

ウェブサイト

www.tokenwell.com

本社

Vancouver, Canada

設立

2026

Tokenwell Platforms Inc is listed in the Finance sector of the Canadian Securities Exchange with ticker TWEL. The last closing price for Tokenwell Platforms was $0.02. Over the last year, Tokenwell Platforms shares have traded in a share price range of $ 0.02 to $ 0.48.

Tokenwell Platforms currently has 61,533,092 shares in issue. The market capitalisation of Tokenwell Platforms is $1.54 million. Tokenwell Platforms has a price to earnings ratio (PE ratio) of -0.20.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.005	25	0.02	0.025	0.02	106350	0.02	CS
4	-0.005	-16.6666666667	0.03	0.03	0.02	111627	0.02116769	CS
12	-0.04	-61.5384615385	0.065	0.065	0.02	108421	0.02983839	CS
26	-0.1	-80	0.125	0.15	0.02	70566	0.05054484	CS
52	-0.315	-92.6470588235	0.34	0.48	0.02	85485	0.20772802	CS
156	-0.315	-92.6470588235	0.34	0.48	0.02	85485	0.20772802	CS
260	-0.315	-92.6470588235	0.34	0.48	0.02	85485	0.20772802	CS

TWEL - Frequently Asked Questions (FAQ)

What is the current Tokenwell Platforms Inc share price?

The current share price of Tokenwell Platforms Inc is $ 0.025

How many Tokenwell Platforms Inc shares are in issue?

Tokenwell Platforms Inc has 61,533,092 shares in issue

What is the market cap of Tokenwell Platforms Inc?

The market capitalisation of Tokenwell Platforms Inc is CAD 1.54M

What is the 1 year trading range for Tokenwell Platforms Inc share price?

Tokenwell Platforms Inc has traded in the range of $ 0.02 to $ 0.48 during the past year

What is the PE ratio of Tokenwell Platforms Inc?

The price to earnings ratio of Tokenwell Platforms Inc is -0.2

What is the registered address of Tokenwell Platforms Inc?

The registered address for Tokenwell Platforms Inc is 333 Terminal Avenue, Vancouver, British Columbia, V7A 4C1

What is the Tokenwell Platforms Inc website address?

The website address for Tokenwell Platforms Inc is www.tokenwell.com

Which industry sector does Tokenwell Platforms Inc operate in?

Tokenwell Platforms Inc operates in the Capital Markets sector

biotechinvestor1

biotechinvestor1 5分前

Yes, I saw that. The Merck response (paper 145) to this review request is also posted on the PTAB.
Both sides make some good arguments, but Halozyme’s points are far more compelling.
If Halozyme inference that PTAB director’s rejection of the PGR 087 was based on an RPI issue, then it

?? WALLSTREET SIGNAL ??

?? WALLSTREET SIGNAL ?? 5分前

Special News | Cadrenal Therapeutics, Inc. (Nasdaq: CVKD ), a biopharmaceutical company developing innovative therapies

for serious immune and thrombotic conditions, announced that late-breaking clinical data on its 12-lipoxygenase (12-LOX) inhibitor, CAD-1005

(formerl

?? WALLSTREET SIGNAL ??

?? WALLSTREET SIGNAL ?? 5分前

Special News | Cadrenal Therapeutics, Inc. (Nasdaq: CVKD ), a biopharmaceutical company developing innovative therapies

for serious immune and thrombotic conditions, announced that late-breaking clinical data on its 12-lipoxygenase (12-LOX) inhibitor, CAD-1005

(formerl

dexprs

Sold VSEC and FCFS for gains.

vlispxpert

vlispxpert 7分前

don estaban

don estaban 7分前

More selling !!!

vlispxpert

vlispxpert 7分前

glenn1919

glenn1919 7分前

OPTU.....ICCM.......LHSW.......LPA.......LFS.......https://stockcharts.com/sc3/ui/?s=OPTU&p=d&yr=0&mn=2&dy=12&id=p84071410134

gitreal

gitreal 7分前

You stated a falsehood (you lied), and you needed to be corrected. Got any more misinformation today?

CryptoRain

CryptoRain 8分前

Ascm trying to shake people out. It’s a trap..they hope😂😂

luckydude777

luckydude777 8分前

ADTX building a foundation

jcromeenes

jcromeenes 9分前

I doubt Trump knows that rule.

nowwhat2

nowwhat2 9分前

And would you like some milk with that toast there ?......Or no.
.

spirogyra

spirogyra 10分前

Type things correctly, he says! Ghetto. Not getto. Hahahahaha.

vlispxpert

vlispxpert 11分前

MSTX my $9.86 gtc order filled, forgot I set it for $10 sweep lol

Miamifl

Miamifl 11分前

Gimmee- I’m on the road, but tonight I will send the post that I thought said it. And again, maybe I was not reading it right

seventhcircle

seventhcircle 11分前

$AIMN As Healthcare Breaches Hit a Record and Move to Third-Party Providers, AimwellBio.com Explores a Redundancy Layer Built to Survive the Vendor https://www.otcmarkets.com/stock/AIMN/news/AIMN-As-Healthcare-Breaches-Hit-a-Record-and-Move-to-Third-Party-Providers-AimwellBiocom-Explores-a-Redundan

seventhcircle

seventhcircle 11分前

$AIMN As Healthcare Breaches Hit a Record and Move to Third-Party Providers, AimwellBio.com Explores a Redundancy Layer Built to Survive the Vendor https://www.otcmarkets.com/stock/AIMN/news/AIMN-As-Healthcare-Breaches-Hit-a-Record-and-Move-to-Third-Party-Providers-AimwellBiocom-Explores-a-Redundan

seventhcircle

seventhcircle 12分前

$AIMN As Healthcare Breaches Hit a Record and Move to Third-Party Providers, AimwellBio.com Explores a Redundancy Layer Built to Survive the Vendor https://www.otcmarkets.com/stock/AIMN/news/AIMN-As-Healthcare-Breaches-Hit-a-Record-and-Move-to-Third-Party-Providers-AimwellBiocom-Explores-a-Redundan

seventhcircle

seventhcircle 12分前

$AIMN As Healthcare Breaches Hit a Record and Move to Third-Party Providers, AimwellBio.com Explores a Redundancy Layer Built to Survive the Vendor https://www.otcmarkets.com/stock/AIMN/news/AIMN-As-Healthcare-Breaches-Hit-a-Record-and-Move-to-Third-Party-Providers-AimwellBiocom-Explores-a-Redundan

underpar71

underpar71 15分前

No volume. No updates from the company. MHRA pushes inquiries back to the company. No clean rooms. No partnerships. No FDA application. No new trials.
And now everyone is on the edge of their seat waiting for Bosch to speak in 10 days. What happens when that is a non event or even worse, what

Boston-Bets

Boston-Bets 18分前

Yikes:

https://www.cnbc.com/2026/06/24/trump-cancels-housing-bill-signing-save-america-act.html

tm3141

tm3141 18分前

i am totally lost - what does the Act have to do with housing bill? also, i thought it’s *his* EO to limit the purchases of houses by institutional investors? is the housing bill not a good thing at all, not really for the benefit of american people?

ducci1

ducci1 18分前

Bulls-----R3 By/Sigs-----Last 2 Rallies were Marked by 3 Highers Hi's 30 min Macd's on SPX/ES/SPY----Mainly I Watch SPX//ES ---Can Allso be triggered by CCI Same Divergence ---( Dats Y 30 min Mother of All Charts ! )---Just Sharing!!

US Market News

US Market News 19分前

Morgan Stanley Bank, N.A. Receives Outstanding Rating for Community Reinvestment InitiativesJune 24, 2026 11:00 AM
Business Wire Rating given by the Office of the Comptroller of the Currency Morgan Stanley Bank, N.A1., a national bank subsidiary of Morgan Sta

Tokenwell Platforms

Prodigy Gold NL

VanEck Durable High Divi...

Amundi Nasdaq100 Swap UC...

DAXsector All Industrial...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。